340B Drug Pricing Program
For 25 years, the 340B drug savings program, at no cost to the government, has enabled eligible hospitals to purchase certain outpatient drugs from pharmaceutical manufacturers at discounted prices. This allows the participating hospitals to use the savings from the discounts to provide an expanded…
Brief of 32 State and Regional Hospital Associations as Amici Curiae in Support of Plaintiffs' Motion for a Preliminary Injunction and in Opposition to Defendants' Motion to Dismiss
A bipartisan group of six senators yesterday urged Senate leadership to include in a year-end package, legislation that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B drug savings program. The Centers for Medicare & Medicaid…
A bipartisan group of six senators yesterday urged Senate leadership to include in a year-end package, legislation that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B drug savings program. The Centers for Medicare & Medicaid…
The Health Resources and Services Administration is reminding hospitals that participate in the 340B drug savings program that they must recertify by Dec. 6 or they will be terminated from the program. HRSA is required to recertify annually all participating covered entities enrolled in the 340B…
U.S. District Court Judge Rudolph Contreras will hear arguments Dec.
On November 1, CMS released the calendar year (CY) 2018 outpatient prospective payment system (OPPS)/ambulatory surgical center (ASC) final rule; on November 2, it released the CY 2018 Medicare physician fee schedule (PFS) final rule.
Reps. David McKinley (R-WV) and Mike Thompson (D-CA) last night introduced H.R. 4392, a bill that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B Drug Pricing Program.
Reps. David B. McKinley (R-WV) and Mike Thompson (D-CA) November 14 introduced H.R. 4392 a bill that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B Drug Pricing Program.
The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today filed a federal lawsuit to prevent the Centers for Medicare & Medicaid Services from reducing Medicare payments for hospital outpatient drugs under the 340B Drug Pricing Program by nearly 30%.